| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | WO1996014846A1 Dihydropyrimidines and uses thereof |
| 05/23/1996 | WO1996014748A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS |
| 05/23/1996 | WO1996009826A3 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 05/23/1996 | CA2205414A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | CA2204886A1 Amelioration of human erectile dysfunction by treatment with inos, and related nos agents |
| 05/22/1996 | EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
| 05/22/1996 | EP0521914B1 A method for regulating neuron development and maintenance |
| 05/21/1996 | US5519138 Angiotensin antagonist |
| 05/21/1996 | US5519006 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 05/21/1996 | US5519002 Lutenizing hormone releasing hormone and an immunogenic conjugate |
| 05/21/1996 | US5518733 Cosmetic compositions containing oligosaccharides |
| 05/17/1996 | WO1996014410A1 Human scf, a splice variant thereof, its pharmaceutical use |
| 05/17/1996 | WO1996014339A1 Antibodies |
| 05/17/1996 | WO1996014316A1 A method of treating urinary bladder dysfunctions |
| 05/17/1996 | WO1996014300A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities |
| 05/17/1996 | WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 05/17/1996 | WO1996014066A1 A method of treating urinary bladder dysfunctions |
| 05/15/1996 | EP0711757A1 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists |
| 05/15/1996 | EP0711290A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 05/15/1996 | EP0711289A1 Piperazine compounds used in therapy |
| 05/15/1996 | EP0711168A1 Methods of treating apoptosis and associated conditions |
| 05/15/1996 | EP0711157A1 Endothelin receptor antagonists |
| 05/15/1996 | CN1122226A Tablet, capsule, or granule comprising desogestrel |
| 05/14/1996 | US5516774 Treating diseases characterized by excess renal reabsorption of water |
| 05/14/1996 | US5516769 Administering an antiprogestin to prevent ovulation or interfere with the menstrual cycle of a mammal |
| 05/14/1996 | US5516764 Anti-inflammatory agent |
| 05/14/1996 | US5516653 Genetic engineering |
| 05/09/1996 | CA2162089A1 ¬3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy|-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists |
| 05/08/1996 | EP0710657A1 Antagonists of adhesion receptors |
| 05/08/1996 | EP0710235A1 Endothelin antagonists |
| 05/08/1996 | EP0585440B1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 05/02/1996 | WO1996012797A1 Production and use of human and plant methyltransferases |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | WO1996012494A1 Competitive progesterone antagonists for regulating female fertility as required |
| 05/02/1996 | CA2203541A1 Competitive progesterone antagonists for demand-oriented female birth control |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203265A1 Production and use of human and plant methyltransferases |
| 05/01/1996 | EP0709394A2 Steroids with a 17-spiromethylene lactone or lactol group |
| 05/01/1996 | EP0709375A2 Therapeutic heterocycles |
| 05/01/1996 | EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| 05/01/1996 | EP0708657A1 Compositions for nasal administration of desmopressin |
| 05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 05/01/1996 | EP0708647A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 05/01/1996 | EP0457883B1 New bicyclic amino-substituted compounds |
| 05/01/1996 | CN1121709A Oxytocin antagonist |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 04/30/1996 | US5512580 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation |
| 04/30/1996 | US5512563 Tricyclic benzazepine vasopressin antagonists |
| 04/30/1996 | US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site |
| 04/30/1996 | CA1338287C Hetrazepines and processes for preparing them |
| 04/28/1996 | CA2161490A1 Steroids with a 17-spiromethylene lactone or lactol group |
| 04/25/1996 | WO1996011914A1 New carboxylic acid derivatives, their preparation and their use |
| 04/25/1996 | WO1996011685A2 Use of indole derivatives for the treatment of various diseases |
| 04/24/1996 | EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists |
| 04/24/1996 | EP0707850A1 Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain |
| 04/24/1996 | EP0707490A1 Neuropeptide y antagonists and agonists |
| 04/24/1996 | EP0450097B1 Benzoheterocyclic compounds |
| 04/24/1996 | CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them |
| 04/23/1996 | US5510386 Aminosulfonylphenyl compounds for treating urinary incontinence |
| 04/23/1996 | US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders |
| 04/23/1996 | US5510345 Biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 04/23/1996 | US5510341 Ovulation-inhibiting preparation for hormonal contraception |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | DE19533023A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use |
| 04/17/1996 | EP0706994A1 Melatonergic agents |
| 04/17/1996 | EP0706533A1 Synthetic peptides of human papillomavirus |
| 04/17/1996 | EP0706525A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 04/17/1996 | CN1120844A Phosphonomethyldipeptides |
| 04/17/1996 | CN1120838A Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 04/17/1996 | CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them |
| 04/17/1996 | CN1120442A Pudenda lotion and its prepn. method |
| 04/17/1996 | CN1031574C Process for preparation of 4-amino-delta-4, 6-steroid(s) compounds |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/16/1996 | US5508306 Used for treatment of benign prostatic hyperplasia, lowering intraocular pressure and inhibiting cholesterol synthesis |
| 04/16/1996 | US5508284 Treating 5-hydroxytryptamine modulation |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/11/1996 | WO1996010416A1 DRUGS CONTAINING β-INTERFERON |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2199154A1 The use of medicaments containing interferon-beta |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0705266A1 Process for producing imidazole derivative |
| 04/10/1996 | EP0705244A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 04/10/1996 | EP0504254B1 The use of gibberellins for the manufacture of a medicament for the treatment of prostatitis |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120337A Process for production of an imidazole derivative |
| 04/09/1996 | US5506270 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| 04/09/1996 | US5506207 GNRH antagonists XIII |
| 04/09/1996 | CA1338238C Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009826A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | CA2200858A1 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704057A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 04/03/1996 | EP0703924A1 Biologically active vasopressin analogues |